Jost Fischer
Chairman at AEON BIOPHARMA, INC.
Net worth: 185 351 $ as of 2024-04-29
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Marc Forth | M | 53 | 5 years | |
Peter Reynolds | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Eric Carter | M | 72 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Shelley Thunen | F | 71 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Robert Palmisano | M | 79 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
David Kim | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 7 years |
Chad Oh | M | 66 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
Darren O Brien | M | 48 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA.
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | 1 years |
Domenico Nicolia | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 6 years |
Alex Wilson | M | 38 | 3 years | |
Richard Taketa | M | 52 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 6 years |
Jon Santemma | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 6 years |
Chris Carr | M | 54 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
Scott Asnis | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Ed Inal | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 2 years |
Kevin yu | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Bobby Buka | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Surinder Sandhu | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Daniel Straus | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Robert Grant | M | - |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | - |
Terry Wang | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 6 years |
Rick Taketa | M | - |
Alphaeon 1 LLC
Alphaeon 1 LLC Financial ConglomeratesFinance Alphaeon 1 LLC operates as investment holding company. The company was founded in 2020 and is headquartered in Newport Beach, CA. | - |
Joshua U. Klein | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Vikram Malik | M | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 10 years |
Joseph Ibrahim | M | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 3 years |
William Sanger | M | 73 |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Sheila Schweitzer | F | 77 |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Simone Blank | F | 61 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Adelbert L. Stagg | M | 77 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 5 years |
Jeffrey Slovin | M | 59 |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | - |
Blair Durst | F | - |
Regal Healthcare Capital Management LLC
Regal Healthcare Capital Management LLC Investment ManagersFinance Regal Healthcare Capital Management LLC (Regal Healthcare Capital) is a private equity firm founded in 2018 by Jon Santemma and David Kim. The firm is headquartered in New York. | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jonathan I. Friedman | M | 53 | - | |
Thomas Jetter | M | 67 | - | |
Murthy Simhambhatla | M | 58 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 3 years |
Harry Kraemer | M | 69 | - | |
Walter Petersohn | M | 57 |
Sirona Holding GmbH
Sirona Holding GmbH Medical SpecialtiesHealth Technology Sirona Holding GmbH operates as a holding company with interest in medical equipment manufacturing industries. It's operating companies manufacture handpieces, hygiene systems, imaging systems and CAD/CAM systems. Founded in 1997, the company is headquartered in Bensheim, Germany. | 15 years |
John Sweeney | M | - | - | |
Gregory P. Leahy | M | - | 1 years | |
Arthur D. Kowaloff | M | 77 | 12 years | |
Theo Haar | M | 76 | 4 years | |
Timothy Sullivan | M | 66 | 11 years | |
Tim D. Sheehan | M | 52 | 6 years | |
Nicholas Alexos | M | 60 | 6 years | |
David B. Schick | M | - | 12 years | |
Robert Hayman | M | 65 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 4 years |
Rui Avelar | M | 62 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 4 years |
John Joseph Knappenberger | M | 77 |
Northrop Grumman Space & Mission Systems Corp.
| 6 years |
Walter Aspatore | M | 81 |
Northrop Grumman Space & Mission Systems Corp.
| 1 years |
Chi Hiu Robert Chow | M | - |
Northrop Grumman Space & Mission Systems Corp.
| 4 years |
Robert Sanchez | M | - |
Northrop Grumman Space & Mission Systems Corp.
| 6 years |
Rainer Berthan | M | 60 | - | |
Dave K. Beecken | M | 77 | - | |
Franz-Werner Haas | M | 54 | - | |
Stephan Mitsdörffer | M | 55 | - | |
Kristine Romine | M | 59 |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Michael Stevens | M | - |
AEON Biopharma Sub, Inc.
AEON Biopharma Sub, Inc. Pharmaceuticals: OtherHealth Technology AEON Biopharma Sub, Inc. is a biopharmaceutical company. It focuses on developing a proprietary botulinum toxin complex, ABP-450, for debilitating medical conditions, with an initial focus on the neurology and gastroenterology markets. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Newport Beach, CA. | 1 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 54 | 96.43% |
Germany | 1 | 1.79% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Jost Fischer
- Personal Network